Publications by authors named "Dipti Pawaskar"

Claim this Profile
P
Pharmacokinetics, Pharmacodynamics, and Safety of Subcutaneous and Intravenous Garadacimab Following Single-Dose Administration in Healthy Japanese and White Adults.
Fiona Glassman, John-Philip Lawo, Mihai Alexandru Bica, Anthony Roberts, Dipti Pawaskar

J Clin Pharmacol· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacokinetic/pharmacodynamic modeling for dose selection for the first-in-human trial of the activated Factor XII inhibitor garadacimab (CSL312).
Dipti Pawaskar, Xi Chen, Fiona Glassman, Frauke May, Anthony Roberts

Clin Transl Sci· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase I, first-in-human, randomized dose-escalation study of anti-activated factor XII monoclonal antibody garadacimab.
Andrew McKenzie, Anthony Roberts, Sourabh Malandkar, Henrike Feuersenger, Con Panousis, Dipti Pawaskar

Clin Transl Sci· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prophylactic use of an anti-activated factor XII monoclonal antibody, garadacimab, for patients with C1-esterase inhibitor-deficient hereditary angioedema: a randomised, double-blind, placebo-controlled, phase 2 trial.
Timothy Craig, Markus Magerl, Donald S Levy, Avner Reshef, William R Lumry, Dipti Pawaskar

Lancet· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-Term Outcomes with Subcutaneous C1-Inhibitor Replacement Therapy for Prevention of Hereditary Angioedema Attacks.
Timothy Craig, Bruce Zuraw, Hilary Longhurst, Marco Cicardi, Konrad Bork, Dipti Pawaskar

J Allergy Clin Immunol Pract· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
C1 Inhibitor Activity and Angioedema Attacks in Patients with Hereditary Angioedema.
Allen P Kaplan, Dipti Pawaskar, Joseph Chiao

J Allergy Clin Immunol Pract· March 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Population pharmacokinetics of subcutaneous C1-inhibitor for prevention of attacks in patients with hereditary angioedema.
Dipti Pawaskar, Michael A Tortorici, Bruce Zuraw, Timothy Craig, Marco Cicardi

Clin Exp Allergy· October 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Subcutaneous C1-esterase inhibitor to prevent hereditary angioedema attacks: Safety findings from the COMPACT trial.
H Henry Li, Sarah Mycroft, Sandra Christiansen, Daniel N Wood, Henrike Feuersenger, Dipti Pawaskar

Allergy Asthma Proc· September 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Exposure-Response Model of Subcutaneous C1-Inhibitor Concentrate to Estimate the Risk of Attacks in Patients With Hereditary Angioedema.
Ying Zhang, Michael A Tortorici, Dipti Pawaskar, Ingo Pragst, Thomas Machnig

CPT Pharmacometrics Syst Pharmacol· March 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prevention of Hereditary Angioedema Attacks with a Subcutaneous C1 Inhibitor.
Hilary Longhurst, Marco Cicardi, Timothy Craig, Konrad Bork, Clive Grattan, Dipti Pawaskar

N Engl J Med· March 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Physiologically based pharmacokinetic models for everolimus and sorafenib in mice.
Dipti K Pawaskar, Robert M Straubinger, Gerald J Fetterly, Bonnie H Hylander, Elizabeth A Repasky

Cancer Chemother Pharmacol· May 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Synergistic interactions between sorafenib and everolimus in pancreatic cancer xenografts in mice.
Dipti K Pawaskar, Robert M Straubinger, Gerald J Fetterly, Bonnie H Hylander, Elizabeth A Repasky

Cancer Chemother Pharmacol· May 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Interactions of everolimus and sorafenib in whole blood lymphocyte proliferation.
Dipti K Pawaskar, Robert M Straubinger, Gerald J Fetterly, Wen W Ma, William J Jusko

Pharm Res· March 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Interactions of everolimus and sorafenib in pancreatic cancer cells.
Dipti K Pawaskar, Robert M Straubinger, Gerald J Fetterly, Wen W Ma, William J Jusko

AAPS J· January 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Methods of utilizing baseline values for indirect response models.
Sukyung Woo, Dipti Pawaskar, William J Jusko

J Pharmacokinet Pharmacodyn· October 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis